Physician profile
Matthew Christopher Comley
NPI 1659754059
$18,989.83
in general payments reported to CMS, 2019-2025
10 companies · $1,550 in 2025
The $1,550 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $709 · 2020: $1,932 · 2021: $12K · 2022: $2,450 · 2024: $13.54 · 2025: $1,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $960 · Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $960.45 |
| Food and Beverage | $602.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $5,000.00 | 2021 | |
| Pylant Medical | $3,885.52 | 2021-2025 | |
| Smith+Nephew, INC. | $2,906.90 | 2020-2021 | |
| Stryker Corporation | $2,726.01 | 2019-2025 | Mako, Insignia |
| Medinc of Texas | $2,400.00 | 2021 | |
| Arthrex, INC. | $1,628.00 | 2021 | |
| Depuy Synthes Sales INC. | $247.74 | 2019-2025 | Na |
| Skeletal Dynamics INC | $124.09 | 2019 | |
| Axogen | $58.03 | 2020 | |
| Nevro Corp. | $13.54 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Comley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.